Dynacq Healthcare, Inc. Announces Reviewed Financial Results for the Fiscal Quarter Ended February 28, 2007.

HOUSTON -- Dynacq Healthcare, Inc. (DYII) today announced reviewed financial results for the fiscal quarter ended February 28, 2007. For the fiscal quarter ended February 28, 2007, net loss decreased by $1,270,393, or 54%, from a net loss of $2,350,779 in 2006 to a net loss of $1,080,386 in 2007. Net patient revenue increased by $942,496, or 11%, from $8,338,667 in 2006 to $9,281,163 in 2007 primarily due to an increase in the number of inpatient cases. Because the Company is seeking a buyer for its Baton Rouge facility, the operating results from this facility has been classified as discontinued operations. During the quarter ended February 28, 2007, the Company sold its West Houston Facility, which had been classified as discontinued operations also. The net patient service revenues at these discontinued operations increased $713,930, or 53%, from $1,337,347 in 2006 to $2,051,277 in 2007.

Dynacq Healthcare, Inc. ("www.dynacq.com") is a holding company. Its subsidiaries provide surgical healthcare services and related ancillary services through hospital facilities.

Certain statements included in this press release, which are not historical facts, are forward-looking statements. Such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent our expectations or beliefs, intentions, future events, future performance, business prospects and involve certain risks and uncertainties, including those described in our public filings with the United States Securities and Exchange Commission, also including, but not limited to, changes in interest rates, competitive pressures, changes in customer mix, changes in third party reimbursement rates, financial stability of major customers, changes in government regulations or the interpretation of these regulations, changes in supplier relationships, growth opportunities, cost savings, revenue enhancements, synergies and other benefits anticipated from acquisition transactions, difficulties relative to integrating acquired business, the accounting and tax treatments of acquisitions, and asserted and unasserted claims, which could cause actual results to differ materially from those indicated in the forward-looking statements. The forward-looking statements by their nature involve substantial risks and uncertainties, certain of which are beyond our control, and actual results may differ materially depending on a variety of important factors. You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date herein. The risks and uncertainties that may cause these forward-looking statements to prove to be incorrect include, without limitation, adverse effects of litigation or regulatory actions, inability to negotiate desired terms with proposed joint venture partners, and favorable regulatory determinations for availability of financing options and other transactions.